Antlia Bioscience, Inc. logo

Antlia Bioscience, Inc.

Turning promising peptides into groundbreaking therapeutics for chronic diseases

4 employees · est. 2021 · Encinitas, United States

VS
Structure Therapeutics logo

Structure Therapeutics

Developing accessible oral small molecule therapies for the treatment of chronic diseases including obesity.

219 employees · est. 2017 · South San Francisco, United...

Structure Therapeutics is the older company (2021 vs 2017); Structure Therapeutics is the larger of the two.

Side-by-Side Comparison

Antlia Bioscience, Inc. Structure Therapeutics
Founded
2021 2017 older
Headquarters
Encinitas, United States South San Francisco, United States
Employees
4 219 larger
Industry
Biotechnology, Health Care Biotechnology, Health Care, Pharmaceutical
Funding Stage
Not tracked yet IPO
Total Funding
Not tracked yet $1.79B
Funding Rounds
Not tracked yet 8
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Therapeutics, Peptides, Chronic Diseases, PASylation®, Pharmacokinetics, Cardiovascular Diseases, Pulmonary Diseases, Metabolic Diseases, Drug Development, Science, Innovation, Pharmaceuticals Life-changing Medicines, Computational Chemistry, Structure-based Technology, Clinical-stage Pipeline, Chronic Diseases, Biologic And Peptide Drugs, Drug Design, Biological Targets, Global Drug Discovery, Metabolic Diseases, Cardiovascular Diseases, Pulmonary Conditions, Diabetes, Obesity, Data Integration
Website
antliabio.com structuretx.com
Antlia Bioscience, Inc. logo

About Antlia Bioscience, Inc.

Antlia Bioscience, Inc. is a biotechnology startup founded in 2020 with a mission to develop revolutionary therapeutics for chronic diseases. Utilizing its proprietary chemistry platform, PASylation®, the company is focused on engineering long-acting peptides with refined pharmacologic and pharmacok...

Structure Therapeutics logo

About Structure Therapeutics

Structure Therapeutics is a biotechnology startup founded in 2016, headquartered in the United States. The company is focused on creating innovative, life-changing medicines for patients using advanced computational and structure-based technology. Its platform integrates computational chemistry and...

We will tell you when either one moves

BounceWatch watches Antlia Bioscience, Inc. and Structure Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Antlia Bioscience, Inc... and Structure Therapeutics — by email.

Frequently Asked Questions

Antlia Bioscience, Inc. — Turning promising peptides into groundbreaking therapeutics for chronic diseases. Structure Therapeutics — Developing accessible oral small molecule therapies for the treatment of chronic diseases including obesity.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Antlia Bioscience, Inc. has raised undisclosed funding while Structure Therapeutics has raised $1.79B.
Antlia Bioscience, Inc. and Structure Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Antlia Bioscience, Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Antlia Bioscience, Inc. on 12 Sep 2024, and Structure Therapeutics on 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy